Sandra Kleinau obtained her Ph.D. in clinical immunology from Uppsala University (UU), Sweden and performed postdoctoral studies at Karolinska Institute in Stockholm and later at UU. She established her own research group in 1997, received a permanent position at UU in 2004 and became Professor of Biology in 2008. Dr Kleinau has a research interest in autoimmunity, articularly autoimmune arthritis; how self reactive lymphocytes and antibodies develop and by which mechanisms they induce chronic inflammation.
Professor of Cell Biology, Chair of the Cell Biology Department University Medical Center (UMC) Utrecht, Head of the Cell Microscopy Center (CMC) of the UMC Utrecht.
Editorial boards of: Traffic, Histochemistry and Cell Biology, Biology of the Cell, Molecul
Päivi Koskinen carried out her PhD studies in Cancer Biology in the University of Helsinki and postdoctoral studies at the Fred Hutchinson Cancer Research Center in Seattle, WA. Currently she works as Senior Lecturer and Group Leader at the Department of Biology in the University of Turku. Her research group is interested in intracellular signalling regulated by mammalian and nematode kinases, and in development of kinase inhibitors for both research and therapeutic purposes.
Principal Investigator, Institute of Cellular Biology and Pathology, First Faculty of Medicine, Charles University in Prague, Albertov 4, 128 00 Prague 2, Czech Republic
& Senior Scientist, Biotechnological center Biocev. Specializes in the biology of Caenorhabditis elegans and other Rhabditidae and regulation of gene expression by nuclear receptors.
Genomics and Molecular Biology of Caenorhabditis elegans, regulation of gene expression by nuclear receptors in nematodes.
Associate Professor at Voiland School of Chemical Engineering & Bioengineering. Former director of the Circular Dichroism facility at Robert Wood Johnson Medical School, Piscataway, NJ.
Staff Scientist at the Spanish National Research Council, CSIC. Our research group at the Centro de Investigaciones Biologicas (CIB) focuses on DNA topology and chromatin organization. I have also a strong interest in gene regulation during erythroleukemia cell differentiation.
Dr. Prasanna earned his BVSc (DVM) degree with honors from Bangalore Veterinary College and completed his Masters and PhD in Veterinary Pathology from Indian Veterinary Research Institute (India's premier institute for Veterinary Research). He completed his postdoctoral training at Northwestern University (in Dr. Raj Kishore's laboratory) and East Tennessee State University. Before joining University of Alabama at Birmingham (UAB), he held faculty appointments at the Feinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Chicago, Illinois and Houston Methodist Research Institute, Texas.
As a member of the Department of Biomedical Engineering, he directs a research program focusing on understanding mechanisms of cardiovascular diseases and developing novel therapeutic strategies to promote cardiac regeneration and repair. Dr. Krishnamurthy’s laboratory is supported through funds from National Institutes of Health (NIH-R01) and American Heart Association (GIA and Postdoctoral fellowships).
Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Senior Lecturer in Biomedical Science and Group Leader, Deakin University; Honorary Senior Research Fellow, The Florey Institute of Neuroscience and Mental Health.
Sharon's research has been funded by the NHMRC and ARC and is focused on the biology of the copper and its role in health and disease. Sharon has held research positions at The Murdoch Children’s Research Institute and at UCLA, USA, was a recipient of a prestigious NHMRC R.D. Wright Award and has published widely in internationally recognised journals. Sharon is a strong advocate for student professional development and career mentoring within the biomedical sciences and medical research through her University teaching and her work on the Victorian Branch of The Australian Society for Medical Research.
Denis L.J. Lafontaine received a research MSc (1991) and a PhD (1995) in Molecular Biology & Genetics from the University of Namur (Belgium) under the supervision of Prof Jean Vandenhaute. He conducted post-doctoral training (1995-2001) with Prof David Tollervey in the Gene Expression program at the European Molecular Biology Laboratory (EMBL, Heidelberg) and The Welcome Trust Center for Cell Biology at the University of Edinburgh. Denis was recruited to a permanent position with the Belgian F.R.S./FNRS in 2001, and since then has worked as a Principal Investigator at the Institute of Molecular Biology & Medecine at the University of Brussels. In 2012 and 2015, he co-organized the International Ribosome Synthesis Meeting in Banff, Canada and Brussels, respectively. Denis is currently a Professor at the University of Brussels and a Research Director with the F.R.S./FNRS. He is a co-founder and co-director of a preclinical imaging center, the Center for Microscopy and Molecular Imaging (Cmmi). He is involved in an international Master on RNA Biochemistry at the University of Lorraine and is acting as a referee for journals in the field of Molecular and Cellular Biology, and for international funding agencies.
Keywords: RNA biology; Ribosome; RNA processing; RNA modification; Nucleolus
Academic Editor PLoS ONE. Recipient of the 2006 Rupert Timpl Award from the International Society for Matrix Biology.
My research goals are to characterise the mechanisms of collagenous tissue development, repair and renewal. Current research interests include understanding the dynamics of collagen synthesis and turnover, the role of stem cells in musculoskeletal homeostasis and the role of glucose in musculoskeletal ageing. Tissues of interest are primarily tendon and ligament but include cartilage, bone, cornea and intervertebral disc, as well as fibrotic tissue.
This research is important because age-related degeneration and loss of function in musculoskeletal tissues is associated with chronic joint pain, limited movement, tendinopathy, ligament damage, intervertebral disc degeneration and osteoarthritis. There is both a loss of tissue integrity and propensity to fibrosis indicating that homeostasis of the collagenous extracellular matrix is lost with age. Understanding the molecular processes that create functional musculoskeletal tissues during development and growth, and which malfunction or cease to operate in aged tissues is key to developing new strategies for tissue engineering, to activate intrinsic stem cell repair mechanisms and to develop beneficial pharmaceutical, dietary or exercise-based interventions in an increasingly aged society.